Looking at those results (distributed evenly each side of 'maybe a little') it seems we're collectively uncertain right now about what JAK1 selectivity really means in practice. Hopefully we get stronger clinical insights (toxicity/efficacy) in coming years! #EULAR2021 @RheumNow https://t.co/jFhVGqpOnb